Ftse Mib
33.770,05
0,07%
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.428,07
2,04%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Evoke Pharma Inc (EVOK) Evoke Pharma Inc (EVOK) Notizie

Evoke Pharma Inc

EVOK
0,4577
-0,0223 (-4,65%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:30:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/4/202414:30GLOBEEvoke Pharma to Host Virtual Key Opinion Leader (KOL)..
21/3/202421:15GLOBEEvoke Pharma Announces Senior Leadership Transition with..
14/3/202421:05GLOBEEvoke Pharma Reports Fourth Quarter and Full Year 2023..
07/3/202422:10GLOBEEvoke Pharma to Report Fourth Quarter and Full Year 2023..
23/2/202422:15EDGAR2Form 8-K - Current report
20/2/202422:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202415:00EDGAR2Form 8-K - Current report
14/2/202413:30GLOBEEvoke Pharma Announces Closing of $7.5 Million Public..
09/2/202423:15EDGAR2Form 8-K - Current report
09/2/202423:14EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
09/2/202413:30GLOBEEvoke Pharma Announces Pricing of Underwritten Public..
09/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
08/2/202412:50EDGAR2Form S-1/A - General form for registration of securities..
11/1/202403:38EDGAR2Form S-1/A - General form for registration of securities..
04/1/202422:30EDGAR2Form S-1/A - General form for registration of securities..
19/12/202314:30EDGAR2Form S-1/A - General form for registration of securities..
15/12/202322:30EDGAR2Form S-1/A - General form for registration of securities..
29/11/202315:00EDGAR2Form 8-K - Current report
27/11/202322:30EDGAR2Form 8-K - Current report
27/11/202314:30GLOBEEvoke Pharma Announces FDA Orange Book Listing of New GIMOTI..
22/11/202322:15EDGAR2Form 8-K - Current report
14/11/202314:30GLOBEUnited States Patent and Trademark Office (USPTO) Grants..
09/11/202322:30EDGAR2Form S-1 - General form for registration of securities under..
09/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:00EDGAR2Form 8-K - Current report
09/11/202314:30GLOBEEvoke Pharma Reports Third Quarter 2023 Financial Results
01/11/202313:30EDGAR2Form 8-K - Current report
31/10/202313:30GLOBEEvoke Pharma & EVERSANA Unveil Cost Savings Real-World Data..
18/10/202314:30GLOBEEvoke Pharma’s Abstract Entitled “Superiority of Nasal Spray..
12/10/202322:30EDGAR2Form 8-K - Current report
14/9/202314:30GLOBEEvoke Pharma Receives Notice of Allowance from USPTO for..
11/8/202315:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/8/202315:03EDGAR2Form 8-K - Current report
10/8/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:30GLOBEEvoke Pharma Reports Second Quarter 2023 Financial Results
07/8/202314:30GLOBEEvoke Pharma and EVERSANA Announce Abstract Acceptance at..
25/7/202314:30GLOBEEvoke Pharma and EVERSANA Announce Abstract Selection for..
21/7/202315:00EDGAR2Form 8-K - Current report
14/6/202314:30GLOBEEvoke Pharma to Host First Key Opinion Leader Webinar on..
15/5/202322:05GLOBEEvoke Pharma Reports First Quarter 2023 Financial Results
09/5/202313:00GLOBEReal-World Data Presented by Evoke Pharma and EVERSANA at..
04/5/202314:30GLOBEEvoke Pharma’s Real-World Healthcare Utilization Data..
Apertura: 0,453 Min: 0,4104 Max: 0,55
Chiusura: 0,48

La tua Cronologia

NASDAQ
EVOK
Evoke Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network